Steven G. DuBois

Statistics

Publications

179

Citations

16.2K

H-Index

Active since

1999

Affiliations

Dana-Farber/Boston Children's Cancer and Blood Disorders Center(Current)

University of California, San Francisco

Harvard University

Dana-Farber Cancer Institute

Children's Hospital of Philadelphia

Steven G. DuBois is an author at Dana-Farber/Boston Children's Cancer and Blood Disorders Center specializing in oncology, medicine, and pediatric oncology.

ORCID

Publications per year

1999–2025

179

Publications

179

Efficacy of Larotrectinib in <i>TRK</i> Fusion–Positive Cancers in Adults and Children

Alexander Drilon, Theodore W. Laetsch, Shivaani Kummar et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

Medicine, Oncology, Pharmacology +16

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

David S. Hong, Steven G. DuBois, Shivaani Kummar et al. · The Lancet Oncology · 2020 · 994 citations · Full text

Medicine, Oncology, Immunotherapy +14

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier et al. · Journal of Clinical Oncology · 2016 · 605 citations · Full text

Medicine, Hematology, Oncology +17

Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Harold J. Burstein, Lada Krilov, Jeanny B. Aragon‐Ching et al. · Journal of Clinical Oncology · 2017 · 601 citations

Medicine, Cancer Biology, Oncology +7

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study

Theodore W. Laetsch, Steven G. DuBois, Leo Mascarenhas et al. · The Lancet Oncology · 2018 · 552 citations · Full text

Medicine, Molecular Biology, Oncology +16

1–5 of 179